Li R, Li X, Zhao J, Meng F, Yao C, Bao E, Sun N, Chen X, Cheng W, Hua H, Li X, Wang B, Wang H, Pan X, You H, Yang J, Ikezoe T Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a- mediated fatty acid oxidation Theranostics 12 (2), 976-998, 2022
Ikezoe T, Noji H, Ueda Y, Kanda Y, Okamoto S, Usuki K, Matsuda T, Akiyama H, Shimono A, Yonemura Y, Kawaguchi T, Chiba S, Kanakura Y, Nishimura J, Ninomiya H, Obara N Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan International Journal of Hematology 115 (4), 470-480, 2022
Fukatsu M, Ohkawara H, Wang X, Alkebsi L, Furukawa M, Mori H, Fukami M, Fukami S, Sano T, Takahashi H, Harada-Shirado K, Kimura S, Sugimoto K, Ogawa K, Ikezoe T The suppressive effects of Mer inhibition on inflammatory responses in the pathogenesis of LPS-induced ALI/ARDS SCIENCE SIGNALING 15 (724), eabd2533, 2022
Suzuki M, Koyama D, Ikeda S, Sukegawa M, Teshirogi M, Misawa K, Tsunoda S Serum IgG and lymphocyte counts are useful for the early detection of infection in patients receiving bendamustine -rituximab therapy Journal of Clinical and Experimental Hematopathology 62 (2), 91-98, 2022
Matsumoto H, Asano T, Tsuchida N, Maeda A, Yoshida S, Yokose K, Fujita Y, Temmoku J, Matsuoka N, Yashiro-Furuya M, Sato S, Irie K, Norikawa N, Yamamoto T, Endo M, Fukuchi K, Ohkawara H, Ikezoe T, Uchiyama Y, Kirino Y, Matsumoto N, Watanabe H, Migita K Behcet's disease with a somatic UBA1 variant:Expanding spectrum of autoinflammatory phenotypes of VEXAS syndrome. Clinical Immunology 238, 108996, 2022
Wasserstein M, Lachmann R, Hollak C, Arash-Kaps L, Barbato A, Renata C Gallagher, Roberto Giugliani, Norberto B Guelbert, Ikezoe T, Olivier Lidove O, Mabe P, Mengel E, Scarpa M, Senates E, Tchan M, Villarrubia J, Chen Y, Furey S, Beth L Thurberg, Zaher A, Kumar M A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: One-year results. Genetics in Medicine 24 (7), 1425-1436, 2022
Iida H, Imada K, Ueda Y, Kudo K, Yokota A, Ito Y, Kiguchi T, Hata T, Nawa Y, Ikezoe T, Uchida T, Morita Y, Kawashima I, Chiba M, Morimoto K, Hirooka S, Miyazaki Y, Ohno R, Naoe T, the Study Group A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia. International Journal of Hematology 115 (5), 694-703, 2022
Misawa K, Yasuda H, Koyama D, Inano T, Inoguchi A, Shirasu C, Takano H, Iwao N, Ando M, Koike M Adult paroxysmal cold hemoglobinuria following mRNA COVID-19 vaccination CASE REPORT 3 (3), 992-995, 2022
Ikezoe T, Ando K, Onozawa M, Yamane T, Hosono N, Morita Y, Kiguchi T, Iwasaki H, Miyamoto T, Matsubara K, Sugimoto S, Miyazaki Y, Kizaki M, Akashi K Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan Cancer Science, 2022
Mori M, Kataoka Y, Harada-Shirado K, Kawano N, Hayakawa M, Seki Y, Uchiyama T, Yamakawa K, Ishikura H, Irie Y, Nishio K, Yada N, Okamoto K, Yamada S, Ikezoe T Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study Thrombosis Journal 20 (1), 33, 2022
Farge D, Frere C, Jean M Connors, Alok A Khorana, Kakkar A, Ay C, Muñoz A, Brenner B, Pedro H Prata, Brilhante D, Antic D, Casais P, María Cecilia Guillermo Esposito, Ikezoe T, Syed A Abutalib, Luis A Meillon-García, Bounameaux H, Pabinger I, Douketis J, International Initiative on Thrombosis and Cancer (ITAC) advisory panel 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 The Lancet Oncology 23 (7), 334-347, 2022
Takahashi H, Mori H, Fukatsu M, Sano T, Harada K, Oikawa M, Takeishi Y, Kimura S, Ohkawara H, Shichishima T, Ikezoe T Successful management of unstable angina in a ravulizumab-treated patient with paroxysmal nocturnal hemoglobinuria Fukushima Journal of Medical Science 68 (3), 2022
Misawa K, Yasuda H, Matsuda H, Hara M, Ochiai T, Koyama D, Takano H, Iwao N, Koike M Development of acute adult T-cell leukemia following PD-1 blockade therapy for lung cancer Internal Medicine 61 (22), 3421-3424, 2022
Matsumoto H, Fujita Y, Fukatsu M, Ikezoe T, Yokose K, Asano T, Tsuchida N, Maeda A, Yoshida S, Hashimoto H, Temmoku J, Matsuoka N, Yashiro-Furuya M, Sato S, Murakami M, Sato H, Sakuma C, Kawashima K, Shakespear N, Uchiyama Y, Watanabe H, Kirino Y, Matsumoto N, Migita K Case report: Coexistence of multiple myeloma and auricular chondritis in VEXAS syndrome Frontiers in Immunology 13, 897722, 2022
Kimura H, Furukawa M, Mori H, Shiga Y, Asai J, Satoh K, Kai T Development of multiple myeloma after 15 years of treatment for polycythemia vera and successful treatment using bortezomib: A case report Clinical Case Reports 10 (11), e6614, 2022
Minakawa K, Ono S, Watanabe M, Sato Y, Suzuki S, Odawara S, Kawabata K, Ueda K, Kenneth E Nollet, Sano H, Ikezoe T, Kikuta A, Ikeda K Evaluation of a quantitative PCR-based method for chimerism analysis of Japanese donor/recipient pairs Scientific Reports 12 (1), 21328, 2022
27th European Hemathology Association Congress (2022.6.9-6.12, Vienna, Austria WEB) Villarrubia J, Wasserstein M, Barbato A, Renata C Gallagher, Giugliani R, Norberto B Guelbert, Julia B Hennermann, Hollak C, Ikezoe T, Lachmann R, Lidove O, Mabe P, Mengel E, Scarpa M, Senates E, Tchan M, Beth L. Thurberg, Yarramaneni A, Andreea M. Rawlings, Kim Y, Kumar M Olipudase alfa for adults with acid sphingomyelinase deficiency: improvements in crossover placebo patients and further improvements in original olipudase alfa patients after 2 years in ascend trial Hemasphere 6 (S3), 2183-2184, 2022
2022 Society of Hematologic Oncology (SOHO) Annual Meeting (2022.9.28-10.1, Houston, America WEB) Daver N, Ikezoe T, Watts J, Hosono N, Ogawa Y, Miyazaki Y, Erba H, Affinito J, Cai H, Dobrowolska H, Eguchi K, Stoudemire J, Watanabe A, Hitron M, Yuda J Phase 1/2, open-label, dose escalation, dose expansion study of menin inhibitor DSP-5336 in adult patients with acute leukemia with and without mixed-lineage leukemia (MLL)-rearrangement or nucleophosmin_1 (NPM1) mutation Blood 140 (Supplement 1), 3371-3372, 2022
41° Congresso Nazionale della Società Italiana di Farmacologia -第 41 回イタリア国際薬理学会- (2022.12.16-12.19, Roma, Italy WEB) Scarpa M, Barbato A, Renata C Gallagher, Giugliani R, Norberto B Guelbert, Julia B Hennermann, Hollak C, Ikezoe T, Robin Lachmann Robin, Lidove O, Mabe P, Mengel E, Senates E, Tchan M, Villarrubia J, Armstrong Nicole M, Beth L. Thurberg, Yarramaneni A, Kim Y, Kumar M, Wasserstein Melissa P Olipudase alfa for adults with acid sphingomyelinase deficiency: improvements in crossover placebo patients and further improvements in original olipudase alfa patients after 2 years in ASCEND trial
The 64th ASH Annual Meeting and Exposition (2022.12.10-12.12, New Orleans, America WEB) Arai H, Chi S, Utsu Y, Masuda S, Aotsuka N, Ueda T, Fukushima K, Ikeda D, Hosono N, Yamauchi T, Yoshimoto G, Horiguchi H, Iyama S, Kanda J, Katagiri S, Gotoh A, Koyama D, Ikezoe T, Kondo T, Nakamura Y, Ogasawara F, Fukuhara S, Izutsu K, Yamauchi N, Yuda J, Minami Y A practice-oriented genome profiling study with the novel halo-shape annealing and defer-ligation enrichment (HANDLE) system Blood 140 (Supplement 1), 10722–10724, 2022
ASMD web seminar ～肝脾腫を合併する代謝疾患を見逃さないために～ (2022.7.20, WEB) 池添隆之 教育発表:見逃してはいけない血小板減少と肝脾腫を合併する希少疾患 ～成人ASMD 症例における診断までの経緯～
第 5 回 Research Exchange / Molecular Biology Network (2022.8.5, 福島) 深津真彦 Gas6 / TAM 受容体に着目した血液疾患の病態・治療研究
福島県医療ソーシャルワーカー協会 エイズとソーシャルワーク委員会 研修会 (2022.8.20, 福島) 木村 哲 福島県の HIV 診療の現状と課題
第 20 回 国際ライソゾーム病 Web カンファランス (2022.9.7, WEB) 池添隆之 What would you suspect when you see a case with throrombopenia and hepatosplenomegaly? -the background leading up to the diagnosis of adult ASMD-
Acute leukemia web seminar (2022.9.21, WEB) 池添隆之 特別講演Ⅱ:ALL に合併する血液凝固異常のマネージメントについて
第 84 回 日本血液学会学術集会 (2022.10.14-10.16, 福岡 WEB) Suzuki K, Kastritis E, Kim K, Merlini G, Palladini G, Ashutosh D. Wechalekar, Jaccard A, Dispenzieri A, Sanchorawala V, Simon D. Gibbs, Mollee P, Christopher P. Venner, Schonland S, Lu J, Shimazaki C, Jin Seok Kim, Ikezoe T, Chang-Ki Min, Zhou F, Cai Z, Chen X, Iida S, Katoh N, Fujisaki T, Ho-Jin Shin, Tran N, Qin X, Sandra Y. Vasey, Raymond L. Comenzo Daratumumab + bortezomib/cyclophosphamide/dexamethasone in AL amyloidosis: ANDROMEDA update
第 84 回 日本血液学会学術集会 (2022.10.14-10.16, 福岡 WEB) Sawa M, Miyamoto T, Hee-Je Kim, Hiramatsu Y, June-Won Cheong, Ikezoe T, Naoe T, Akashi K, Morita S, Hasabou N, Elizabeth Shima Rich, Kosako M, Uemura E, Terada W, Kadokura T, Hill J, Miyawaki S Gilteritinib with chemotherapy in patients with newly diagnosed acute myeloid leukaemia
第 84 回 日本血液学会学術集会 (2022.10.14-10.16, 福岡 WEB) 尾張真維, 小山大輔, 佐藤佑紀, 深津真彦, 原田佳代, 木村 哲, 福地恒一郎, 遠藤麻美子, 林 清人, 高橋裕志, 三田正行, 池添隆之 Immunosuppressive therapy with EPAG induced expansion of PNH clone in a patient with aplastic anemia
第 84 回 日本血液学会学術集会 (2022.10.14-10.16, 福岡 WEB) 福地恒一郎, 小山大輔, 遠藤麻美子, 佐藤佑紀, 尾張真維, 林 清人, 深津真彦,高橋裕志, 原田佳代, 木村 哲, 池添隆之 Venetoclax based combination as a therapeutic option for BPDCN associated with clonal hematopoiesis
第 84 回 日本血液学会学術集会 (2022.10.14-10.16, 福岡 WEB) 臼杵憲祐, 石山 謙, 池添隆之, 後藤明彦, Karl Johan Myren, Ioannis Tomazos, 下野明彦, 二宮治彦, 櫻井政寿, 中尾眞二, 西村純一 日本人発作性夜間ヘモグロビン尿症患者におけるラブリズマブ対エクリズマブの選好
第 84 回 日本血液学会学術集会 (2022.10.14-10.16, 福岡 WEB) 西村早織, 松本勇人, 池添隆之, 中村研一, 三田正行 AML with CBFB-MYH11 in an elderly patient treated with venetoclax and azacitidine
第 84 回 日本血液学会学術集会 (2022.10.14-10.16, 福岡 WEB) 高橋美咲, 津山尚宏, 工藤健一, 阿左見佑介, 深見美和, 池添隆之, 小野寺雅史,坂井 晃 Attempts to induce t(11;14) during the redifferentiation of iPS cells into B cells
第 84 回 日本血液学会学術集会 (2022.10.14-10.16, 福岡 WEB) 河野徳明, 池添隆之, 和田英夫, 吉田周郎, 栗山拓郎, 栃木太郎, 仲池隆史, 下川知則, 山下 清 The clinical impact of high leukocytes, high LDH, and high HMGB-1 in acute leukemia with ICH and DIC
第 84 回 日本血液学会学術集会 (2022.10.14-10.16, 福岡 WEB) 深津真彦, 佐藤佑紀, 福地恒一郎, 遠藤麻美子, 尾張真維, 林 清人, 高橋裕志,原田佳代, 小山大輔, 木村 哲, 池添隆之 Retrospective validation of the prognostic value of EASIX in Japanese alloHCT recipients
第 84 回 日本血液学会学術集会 (2022.10.14-10.16, 福岡 WEB) 三澤恭平, 安田 肇, 小山大輔, 稲野資明, 高野弥奈, 岩尾憲明, 小池道明 Rare case of adult paroxysmal cold hemoglobinuria following the mRNA COVID-19 vaccination
第 84 回 日本血液学会学術集会 (2022.10.14-10.16, 福岡 WEB) 桑名由希子, 林 清人, 大野沙耶香, 清水 亮, 石井昭広, 田中宏明 Positioning of venetoclax therapy in AML treatment: current status at our hospital
第 84 回 日本血液学会学術集会 (2022.10.14-10.16, 福岡 WEB) 大野沙耶香, 久保寺 愛, 林 清人, 清水 亮, 村上未樹, 鈴木良夫, 田中宏明 A case of intralymphatic large B-cell lymphoma with pathological appearance of castleman's disease
